NCT00001550View on ClinicalTrials.gov

Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 1996

Study Completion Date

May 31, 2002

Conditions
Muscle RigiditySpasmStiff Man Syndrome
Interventions
DRUG

IVIg

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00001550 - Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS) | Biotech Hunter | Biotech Hunter